Clasp Therapeutics

Cytospire Therapeutics

This company develops multispecific immune cell engager antibodies for cancer patients to enhance and direct immune system activity against solid tumours.

Daylight Biotherapeutics

This company develops T-cell engaging therapies for cancer patients to eliminate tumours while reducing systemic immune toxicity.

Captain T Cell

The company develops cell therapies for cancer patients to treat solid tumours.

Cold Start Therapeutics

This company develops multimeric fusion proteins using machine learning to target cancer cells and engage immune cells for patients with oncological diseases.

A2 Biotherapeutics

This company develops logic-gated T-cell therapies to treat patients with solid tumours by selectively targeting cancer cells while sparing healthy tissue.

Neogene Therapeutics

This biotechnology company develops engineered T cell receptor therapies targeting neoantigens in solid cancers for patients with oncology needs.

3T Biosciences

The company develops T-cell receptor therapeutics and target identification technologies for oncology patients to treat solid tumours.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.